Cancer History ProjectFree ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved March 24, 2023Vol.49 No.12By Paul Goldberg
Cancer History ProjectConversation with The Cancer LetterFree Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization March 24, 2023Vol.49 No.12By Paul Goldberg
Cancer History ProjectConversation with The Cancer LetterFree Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story” March 24, 2023Vol.49 No.12By Paul Goldberg
NCI Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality March 24, 2023Vol.49 No.12By Matthew Bin Han Ong
Trials & Tribulations Does salpingectomy prevent ovarian cancer? Let’s prove it.The SOROCk clinical trial, NRG CC008 (NCT04251052) March 17, 2023Vol.49 No.11By Kathryn P. Pennington, Warner K. Huh, Sandra Russo and Joan L. Walker
White House Biden requests $503M increase for NCI, new funds for the Moonshot, $1B for ARPA-H in FY24 March 10, 2023Vol.49 No.10By Matthew Bin Han Ong
Funding Opportunities Cancer Grand Challenges announces global research funding opportunity with nine new challenges March 10, 2023Vol.49 No.10
Clinical Roundup NCI Center for Cancer Research study identifies ecDNA as driver of SCLC March 10, 2023Vol.49 No.10
Grant-funded, investigator-initiated trials fail to bounce back from COVID as 50% of research staff left for higher-paying jobs February 17, 2023Vol.49 No.07By Matthew Bin Han Ong
Drugs & Targets Gritstone bio and NCI collaborate to evaluate neoantigen cell therapy + vaccine for mutant KRAS solid tumors February 17, 2023Vol.49 No.07
